Figure 5. Extract-based co-immunoprecipitations.
Experiments were conducted as described under Materials and Methods. Photographs of ECL-stained immunoblots are shown. A, Immunoprecipitations (IP) of MEF cell extracts with anti-AAG antibody or control non-immune IgG: Top panel, immunoblotting to detect pol β; bottom panel, immunoblotting to detect AAG. In the top panel, IP incubations were performed using matched wild-type (AAG +/+) (lanes 1 and 2) and AAG −/− cell extracts (lane 3) and anti-AAG or non-immune IgG (lane 2); immonoblotting was with anti-pol β antibody. In the bottom panel, immunoblotting was with anti-AAG antibody. In lane 4, 50 µg of AAG +/+ extract (1/20th of the IP input) was subject to SDS-PAGE as a marker for AAG. B, Immunoprecipitations of MEF cell extracts as in A with anti-pol β antibody or non-immune IgG. Top panel, immunoblotting to detect AAG; bottom panel, immunoblotting to detect pol β. Panels C and D illustrate pol λ and OGG1 co-immunoprecipitation from MEF cell extracts, as in panels A and B. IP incubations were performed with matched pol λ+/+ cell extract (lanes 1 and 2) and pol λ−/− cell extract (lane 3), as shown in the figure. Similarly, non-immune IgG was used as a negative control (lanes 2). C. Top panel, immunoblotting to detect OGG1; bottom panel, immunoblotting to detect pol λ. D. Top panel, immunoblotting to detect pol λ; bottom panel, immunoblotting to detect OGG1. In lane 4, 50 µg of pol λ+/+ extract was subject to SDS-PAGE as a marker.
